Atossa Therapeutics
ATOS
#10711
Rank
โ‚ฌ21.4 M
Marketcap
2,14ย โ‚ฌ
Share price
-0.20%
Change (1 day)
207.66%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚ฌ32.15 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ30.13 Million a decrease over its 2024 earnings that were of -โ‚ฌ22.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ32.15 Million6.7%
2025 -โ‚ฌ30.13 Million36.33%
2024 -โ‚ฌ22.1 Million-15.25%
2023 -โ‚ฌ26.08 Million11.62%
2022 -โ‚ฌ23.37 Million30.84%
2021 -โ‚ฌ17.86 Million15.58%
2020 -โ‚ฌ15.45 Million3.41%
2019 -โ‚ฌ14.94 Million51.16%
2018 -โ‚ฌ9.89 Million40.41%
2017 -โ‚ฌ7.04 Million27.54%
2016 -โ‚ฌ5.52 Million-47.49%
2015 -โ‚ฌ10.51 Million-17.25%
2014 -โ‚ฌ12.71 Million35.91%
2013 -โ‚ฌ9.35 Million112.3%
2012 -โ‚ฌ4.41 Million46.53%
2011 -โ‚ฌ3.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.51 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.19 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.19 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ36.11 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ86.18 Million 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ6.8 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA